electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Sector: Electromedical & Electrotherapeutic Apparatus
Industry: Medical - Devices
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 9.04M shares outstanding
USelectroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies.
The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years.
The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Dr. Theofilos
John P. Gandolfo
Chair of the Audit Committee
Joshua S. Lev
CFO & Interim President
Peter S. Staats
Chief Medical Officer
Employees
73
Country
US
Sector
Healthcare
Website
electrocore.com
Loading congressional disclosures…
based on 9.04M shares outstanding
US30d Avg
86.04K
60d Avg
83.68K
90d Avg
81.53K
